IDEXX LABORATORIES INC /DE Other than Temporary Impairment Losses, Investments
IDEXX LABORATORIES INC /DE (IDXX) reported Other than Temporary Impairment Losses, Investments of $150.00 thousand for the 12-month period ending 2009-12-31, per its 10-K filed 2012-02-17.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfInvestments · last filed 2012-02-17
- IDEXX LABORATORIES INC /DE other than temporary impairment losses, investments for the quarter ending 2009-12-31 was $0.00.
- IDEXX LABORATORIES INC /DE other than temporary impairment losses, investments for the quarter ending 2009-09-30 was $0.00.
- IDEXX LABORATORIES INC /DE other than temporary impairment losses, investments for fiscal 2009 was $150.00K.
| Period end | Other than Temporary Impairment Losses, Investments 3 month | Other than Temporary Impairment Losses, Investments 6 month | Other than Temporary Impairment Losses, Investments 9 month | Other than Temporary Impairment Losses, Investments 12 month |
|---|---|---|---|---|
| 2009-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-17 | $0.00 derived: sum of 2 quarters · filed 2012-02-17 | $150.00K 10-K · filed 2012-02-17 | |
| 2009-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-22 | $150.00K 10-Q · filed 2010-10-22 | ||
| 2009-06-30 | $150.00K 10-Q · filed 2010-07-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |